Bank Of Montreal Invitae Corp Put Options Transaction History

Bank Of Montreal

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 01, 2023	SELL	$0.6 - $1.53 $60 - $153	-100 Reduced 0.05%	218,500 $131,000
Q2 2023 Aug 02, 2023	BUY	$1.05 - $1.63 $229,530 - $356,318	218,600 New	218,600 $247,000
Q1 2023 Jun 13, 2024	BUY	$1.2 - $2.73 $190,920 - $434,343	159,100 New	159,100 $214,000
Q3 2022 Nov 10, 2022	SELL	$1.9 - $8.63 $379,240 - $1.72 Million	-199,600 Reduced 40.75%	290,200 $737,000
Q2 2022 Aug 11, 2022	SELL	$2.13 - $9.01 $3,621 - $15,317	-1,700 Reduced 0.35%	489,800 $1.43 Million
Q1 2022 May 12, 2022	BUY	$6.28 - $15.59 $3.08 Million - $7.65 Million	490,700 Added 61337.5%	491,500 $4.13 Million
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $6.9 Million - $13.5 Million	-469,300 Reduced 99.83%	800 $13,000
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $5.7 Million - $7.88 Million	234,500 Added 99.53%	470,100 $13.4 Million
Q2 2021 Aug 12, 2021	BUY	$26.09 - $40.4 $6.15 Million - $9.52 Million	235,600 New	235,600 $8.11 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.